Derazantinib: an investigational drug for the treatment of cholangiocarcinoma.
Expert Opin Investig Drugs. 2021 Nov;30(11):1071-1080. doi: 10.1080/13543784.2021.1995355. Epub 2021 Nov 9.
Expert Opin Investig Drugs. 2021.
PMID: 34698609
Review.